1-(2-Hydroxyethyl)-4,6-dimethyl-2(1H)-pyrimidinone
-
1-(2-Hydroxyethyl)-4,6-dimethyl-2(1H)-pyrimidinone
structure -
-
CAS No:
14716-32-6
-
Formula:
C8H12N2O2
-
Chemical Name:
1-(2-Hydroxyethyl)-4,6-dimethyl-2(1H)-pyrimidinone
-
Synonyms:
2(1H)-Pyrimidinone,1-(2-hydroxyethyl)-4,6-dimethyl-;1-(2-Hydroxyethyl)-4,6-dimethyl-2(1H)-pyrimidinone;N-(β-Hydroxyethyl)-4,6-dimethyl-2-pyrimidone;Xymedon;Xymedone;N-(β-Hydroxyethyl)-4,6-dimethylpyrimidin-2(1H)-one;Ximedon;1-(2-Hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidin-2-one;1-(2-Hydroxy-ethyl)-4,6-dimethyl-1H-pyrimidin-2-one
-
CAS No:
Drug Information
Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)|Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)|Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)
1-(beta-hydroxyethyl)-4,6-dimethyl-1,2-dihydro-2-oxopyrimidine
Computed Properties
Molecular Weight:168.19
XLogP3:-0.5
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:2
Exact Mass:168.089877630
Monoisotopic Mass:168.089877630
Topological Polar Surface Area:52.9
Heavy Atom Count:12
Complexity:256
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation